Iveric Bio is now part of Astellas. Follow Astellas Pharma as we continue advancing therapies in ophthalmology. The Iveric Bio page is no longer active or monitored.
Show more
Show less
Investor insights
Funding rounds participated in
$300M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Funding rounds raised
Total raised
$300M
from investors over 1 rounds
I
Iveric Bio, An Astellas Company raised $300M on December 30, 2022